Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: With $42m, Ex-ignyta Ceo Aims At Cancer Again With Startup, Erasca
Venture Capital

Xconomy: With $42m, Ex-ignyta Ceo Aims At Cancer Again With Startup, Erasca

by xconomy.com posted 1month ago 35 views
A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche, Jonathan Lim is back at it again. Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies. Erasca on Tuesday closed a $42 million Series A round led […]